๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antigens in immune complexes from patients with breast cancer

โœ Scribed by Zvee Gilead; Ada Hatzubai; D. Sulitzeanu


Publisher
Springer-Verlag
Year
1982
Tongue
English
Weight
889 KB
Volume
13
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical significance of circulating imm
โœ G. Krieger; A. Kehl; H.-E. Wander; A.-M. Salo; H. F. Rauschecker; G. A. Nagel ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 541 KB

## Abstract Serum circulating immune complexes (CIC) were repeatedly measured by means of the Cl binding assay (Cba) and the Raji cell assay (Rca) in 158 patients with metastatic breast cancer (mbc). Frequency of occurrence and levels of CIC were only slightly increased in mbc when compared to ageโ€

A prospective study of circulating immun
โœ A. Bukh; M. T. Aguado; N. Krarup; H. S. Poulsen; A. M. Nordentoft; N. P. H. Moll ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 795 KB

Levels of circulating immune complex (clC) and complement split product C3d were studied in 86 patients with breast cancer (BC), 22 patients with benign breast disease (BD), and 72 age-and sex-matched blood-bank donors (NC), using solidphase Clq-protein A RIA, C I q-anti-lgG RIA, anti-C3d anti-lgG R

Serological immune response to cancer te
โœ Andreas Wadle; Boris Kubuschok; Jochen Imig; Beate Wuellner; Christine Wittig; C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 380 KB

## Abstract Serological screening approaches have allowed for the identification of a large number of potentially relevant tumor antigens in cancer patients. Within this group, cancer testis antigens represent promising targets for cancer immunotherapy, since they are widely expressed in a variety

Immune complexes in breast cancer patien
โœ L. D. Papsidero; T. Nemoto; M. C. Snyderman; T. M. Chu ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 408 KB ๐Ÿ‘ 2 views

Levels of Clq binding activity have been measured in the sera of patients with benign and malignant breast disease. Cancer patients showed significantly higher binding activity than patients with gross fibrocystic disease. Clq binding levels were not related to levels of carcinoembryonic antigen, or